Xcout IntelIgnis Therapeutics
Ignis Therapeutics is a biotechnology company established in late 2020 and headquartered in Shanghai, China. The company is dedicated to discovering and developing therapeutics for central nervous system (CNS) diseases.
Subscribe to see Ignis Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Ignis Therapeutics at a glance
Ignis Therapeutics is a biotechnology company headquartered in China. Its most recent funding round, Series A, raised $180M in November 2021. Xcout tracks 13 named people at Ignis Therapeutics, including Vicky Zhang (首席财务官).
Ignis Therapeutics leadership
- Vicky Zhang首席财务官
- 方群首席科学官，翼思脑科学创新研发中心负责人
- 陈连勇翼思生物 董事长
- 黎强首席运营官
- 龙爱晶首席执行官兼首席医学官
- 孙沂杉生物部副总裁
7 more named people on record for Ignis Therapeutics, with roles, board committees and tenure — see the full roster →
Ignis Therapeutics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $180M | 10 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Ignis Therapeutics competitors
A few of Ignis Therapeutics's closest competitors — see the full list of competitors and alternatives →
Inventisbio is a biopharmaceutical company that focuses on the discovery and development of innovative drugs for major diseases such as tumors, autoimmune diseases, and metabolic disorders. Utilizing an independent research and development platform, the company creates proprietary drug pipelines targeting oncology drivers, kinases, and autoimmune pathways to serve patients globally.
Anacalypsis Therapeutics is a biotechnology innovation company based at the Athens Life Tech Park in Greece, focusing on developing medications and biomarkers for central nervous system diseases.
ETERN Therapeutics is a biopharmaceutical company headquartered in Shanghai, China, operating with a strong academic atmosphere and focus on biotechnology.
Axonis Therapeutics, Inc. is a biotechnology company headquartered in Boston, Massachusetts, focused on discovering and developing novel treatments for neurological conditions and spinal cord injuries. Founded in 2019, the company advances therapeutic candidates through its proprietary research platform.
Novoron Bioscience, Inc. is a San Diego-based biotechnology company developing novel therapeutics to address central nervous system and other conditions.
Syremis Therapeutics Ltd. is a clinical-stage biopharmaceutical company headquartered in Tel Aviv, Israel, dedicated to developing novel drug pipeline medicines targeted at treating diseases of the nervous system and mental health disorders.
Get Ignis Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Ignis Therapeutics in Xcout Intel
- 13 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access